© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
PENN FOSTER SCHOOL
104 MAZUR PL
September 15, 2012
FDA approves Lorcaserin and Mirabegron extended-release tablets.
August 10, 2012
FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.
July 15, 2012
FDA approves avanafil and tafluprost
June 15, 2012
FDA approves Lucinactant and Peginesatide